Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
business
business sponsored company news
compliance
medical
research
tc
What
failure
3
×
treatment
3
×
heart
technology
aicure
allowance
announced
awarded
billion
blood
called
clinical
common
company
corinnova
costs
delivered
developing
device
diabetes
diabetics
dollars
drug
effective
emerging
empagliflozin
events
findings
function
healthcare
industry
invasively
medical
medicine
milestone
million
minimally
monitoring
newly
notice
Language
Current search:
failure
×
treatment
×
@slashgear.com
5 years ago
Common blood sugar drug found to reverse heart failure in non-diabetics
@venturebeat.com
6 years ago
CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function
@techcrunch.com
8 years ago
AiCure Raises $12.25 Million For Its Treatment Monitoring Technology
